MENU
MTVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MetaVia (MTVA) Ownership - Who owns MetaVia?
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.71M
P/E Ratio
N/A
Total Cash
11.19M
Projected Growth
N/A
Total Debt
118K
Revenue
N/A
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MTVA
Capitalization
13.7M
P/E Ratio
N/A
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash
11.2M
Total Cash/Share
0.57
Total Debt
118K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.38M
P/B Ratio
3.13
Cash Flow
N/A
Earnings
-2.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
1.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-25.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-168.46
Shares Held By Institutions
1.28M
Shares Outstanding - Current
19.6M
Total Liabilities
7.75M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-65.517
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information